Researchers in the Department of Pathology and Laboratory Medicine at Indiana University School of Medicine have discovered a novel anti-cancer drug, using a unique approach that has allowed them to target previously undruggable cancerous proteins.
When patients with acute stroke symptoms are treated on a mobile stroke unit (MSU) and receive anti-clot medication faster, they have less disability at 90 days, reported a recent study in the New England Journal of Medicine co-authored by Indiana University School of Medicine researcher, Jason Mackey, MD.
Researchers at the Indiana University Melvin and Bren Simon Comprehensive Cancer Center have identified how restoring a missing molecule in pancreatic fibrosis could help deliver treatments to cancer cells.
Indiana University School of Medicine researchers worked in collaboration with an international team of scientists to uncover why certain children get recurring urinary tract infections (UTIs) and others do not.
For people with diabetes who are insulin dependent, glycemic control is a full-time job. But what if their medication could do the work for them—an insulin whose activity in the bloodstream responds to the blood glucose levels and adjusts accordingly?
Feeling anxious about health, family or money is normal for most people—especially during the COVID-19 pandemic. But for those with anxiety disorders, these everyday worries tend to heighten even when there is little or no reason to be concerned.